Cell-penetrating peptides (CPPs) have emerged as powerful tools for intracellular drug delivery, overcoming barriers that hinder the penetration of macromolecular compounds. However, the non-selective nature of CPPs poses safety concerns, prompting the development of smart strategies to enhance targeting delivery while minimizing off-target effects. Various approaches have been explored, including genetic fusion, covalent conjugation, ionic complex formation, and nanoparticle surface modification. These strategies aim to improve drug delivery specificity and efficacy while mitigating potential toxicity concerns.
One key strategy involves the use of prodrugs, where the CPP activity is masked during systemic circulation and unmasked at target tissues, thus sparing normal cells from unwanted penetration. By incorporating stimuli-responsive mechanisms, these prodrug systems can selectively deliver therapeutic agents to specific locations, offering a promising avenue for enhancing drug delivery precision. Additionally, protease-activatable systems have been developed, utilizing cleavable linkers to trigger the release of CPP-linked cargos at target sites, such as tumors, where specific proteases are overexpressed.
Steric hindrance through PEGylation has also been explored to block CPP functionality during circulation, thus preventing non-selective cell penetration and extending systemic circulation time. pH-sensitive bonds have been utilized to trigger the removal of PEG shielding in acidic tumor microenvironments, allowing for the exposure and activation of CPP-mediated cell uptake. Light-induced uncaging strategies have been investigated, enabling precise control over CPP activation using external triggers such as UV light, offering a potential solution to enhance drug delivery specificity.
These smart strategies aim to address the challenges associated with CPP-mediated drug delivery, balancing potency with selectivity to achieve effective and safe intracellular delivery of therapeutic agents. By harnessing the power of CPPs while implementing targeted delivery mechanisms, researchers are paving the way for innovative drug delivery systems that can revolutionize the field of macromolecular drug delivery, offering new possibilities for precise and tailored therapeutic interventions.
Key Takeaways:
– Smart strategies such as prodrug systems and protease-activatable approaches enhance the specificity and safety of CPP-based drug delivery.
– Steric hindrance through PEGylation and pH-sensitive bonds can block CPP functionality during circulation and trigger targeted cell uptake in acidic tumor microenvironments.
– Light-induced uncaging strategies provide precise control over CPP activation, offering a potential solution for enhancing drug delivery specificity and efficacy.
– These innovative approaches hold promise for advancing the field of macromolecular drug delivery, enabling tailored and effective therapeutic interventions.
Tags: upstream, quality control, drug delivery
Read more on pmc.ncbi.nlm.nih.gov